Ticker
SLXNCompany Name
SILEXION THERAPEUTICS CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 5.3M | $ 13.29M | $ -946K | $ 0 | -232.66% |
3/31/2025 | $ 8.43M | $ 13.48M | $ -946K | $ 0 | -148.65% |
12/31/2024 | $ 10.52M | $ 5.35M | $ -250K | $ 0 | -48.53% |
9/30/2024 | $ 3.23M | $ 115.82M | $ -1.03M | $ 0 | -3556.89% |
6/30/2024 | $ 35.63M | $ 90.75M | $ -415K | $ 0 | -253.52% |
3/31/2024 | $ 44.12M | $ -22.15M | $ 1.54M | $ 0 | 46.72% |
12/31/2023 | $ 43.42M | $ -112.9M | $ 1.65M | $ 0 | 256.21% |
9/30/2023 | $ 41.99M | $ -112.9M | $ 1.49M | $ 0 | 265.33% |
6/30/2023 | $ 67.77M | $ -90.75M | $ 1.46M | $ 0 | 131.76% |
3/31/2023 | $ 61.41M | $ -90.75M | $ 985K | $ 0 | 146.18% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for SILEXION THERAPEUTICS CORP is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 143.2M ]
(=) Shareholder Yield [ 0% ]
Minimum
Sep 30, 2024
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |